FDA
approval
· 2026-03-27
FDA Approved: ALLI — Supplemental Application (Haleon US Holdings LLC)
Summary
The FDA approved a supplemental application for ALLI (orlistat) submitted by Haleon US Holdings LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ALLI (ORLISTAT)